Latest financial market updates and expert analysis
Analysis A fresh oncology partnership has once again underscored the yawning gap between Evotec’s research engine and the cold arithmetic of its income statement. The Hamburg-based drug discovery partner announced a...
The mechanics of a stock split rarely tell you much about where a company is headed — they simply reset...
Investors tracking the Norwegian hydrogen pure-play now have fixed dates to work around as the company navigates an unusually quiet...
The calculus on Sivers Semiconductors shifted again this week, this time on the bearish side of the trade. Citadel Securities...
The arithmetic of Bayer’s recovery story is becoming easier to follow, even if the market remains characteristically guarded. The stock...
The arithmetic at BYD is getting harder to reconcile. China’s largest electric vehicle maker just delivered its strongest monthly sales...
The most telling signal about SK Hynix’s trajectory this week had nothing to do with its share price. It came...
The math on Vulcan Energy’s second German lithium project is now on the table, and it makes for ambitious reading....
The software giant’s leadership is putting roughly €900,000 of their own money where their mouths are — just as Wall...
The junior explorer’s strategy is simple: accumulate as much prospective ground as possible, as quickly as possible. The market’s response...
The optics look contradictory on the surface: Ciena’s stock has shed roughly a quarter of its value since the company...
